HL7 Europe Imaging Study Report
0.1.0 - ci-build 150

HL7 Europe Imaging Study Report, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/imaging/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
.... 1.1 Changes
.... 1.2 Adapting Guidelines for Country use
... 2 Actors and Transactions
.... 2.1 System Actors
.... 2.2 Use Cases
.... 2.3 Transactions
... 3 Domain Model
... 4 eHN Imaging Studies and Reports Guidelines
... 5 Design Considerations
... 6 Contributors
... 7 Open Topics
... 8 Artifacts Summary
.... 8.1 A Medical Imaging Report (eHN)
.... 8.2 A.1 Report header data elements (eHN)
.... 8.3 A.1.1 Identification of the patient/subject
.... 8.4 A.1.2 Patient/subject related contact information
.... 8.5 A.1.3 Health insurance and payment information
.... 8.6 A.1.4 Information recipient
.... 8.7 A.1.5 Author
.... 8.8 A.1.6 Legal authenticator
.... 8.9 A.1.7 Result validator
.... 8.10 A.1.8 Document metadata
.... 8.11 A.2 Order information
.... 8.12 A.3 Order Reason
.... 8.13 A.4 Specimen information
.... 8.14 A.5 Examination Report
.... 8.15 A.5.1 Imaging procedure description
.... 8.16 A.5.2 Medication
.... 8.17 A.5.3 Adverse reaction
.... 8.18 A.5.4 Results
.... 8.19 A.5.5 Conclusion
.... 8.20 A.5.6 Recommendation
.... 8.21 A.6 Key images associated with this report
.... 8.22 A.7 Comparison study
.... 8.23 A.8 Presented form
.... 8.24 B Imaging study manifest data set (eHN)
.... 8.25 Imaging Composition
.... 8.26 Imaging Diagnostic Report
.... 8.27 ImagingStudy
.... 8.28 Imaging Study Reports Producer
.... 8.29 Adverse Event
.... 8.30 Allergic Reaction
.... 8.31 Bundle: Imaging Study Report
.... 8.32 Coverage information
.... 8.33 Finding
.... 8.34 Health Insurance Provider
.... 8.35 Imaging Authoring Device
.... 8.36 Imaging Device
.... 8.37 Imaging Key Image Document Reference
.... 8.38 Imaging Order
.... 8.39 Imaging Patient
.... 8.40 Imaging Procedure
.... 8.41 Imaging results from Procedure Phase
.... 8.42 Imaging study performer
.... 8.43 ImBodyStructure
.... 8.44 Impression
.... 8.45 Information Recipient
.... 8.46 Key images represented as an ImagingSelection
.... 8.47 Legal Authenticator
.... 8.48 Medication
.... 8.49 Medication Administration
.... 8.50 Order Placer
.... 8.51 Organization
.... 8.52 Practitioner
.... 8.53 Practitioner Role
.... 8.54 Radiation Dose Observation
.... 8.55 Recommended CarePlan
.... 8.56 Report Author
.... 8.57 Represents the part of an imaging study.
.... 8.58 Result Validator
.... 8.59 Viewer endpoint
.... 8.60 WADO endpoint
.... 8.61 Imaging Accession Number Identifier
.... 8.62 Imaging Accession Number Reference
.... 8.63 Document DiagnosticReport Reference
.... 8.64 Imaging Adverse Event Criticality
.... 8.65 DiagnosticReport supportInfo codes
.... 8.66 Imaging Report Types
.... 8.67 Radiation Dose Observation Unit ValueSet
.... 8.68 CodeSystem for terminology for Endpoint resources used in the EU Imaging IG.
.... 8.69 Diagnostic Report Support Info Code System
.... 8.70 Missing DICOM Terminology
.... 8.71 Mapping of A.1.1 Identification of the patient/subject
.... 8.72 Mapping of A.1.2 Patient/subject related contact information
.... 8.73 Mapping of A.1.3 Health Insurance and Payment Information
.... 8.74 Mapping of A.1.4 Information Recipient
.... 8.75 Mapping of A.1.5 Information Author
.... 8.76 Mapping of A.1.6 Legal Authenticator
.... 8.77 Mapping of A.1.7 Result Validator
.... 8.78 Mapping of A.1.8 Document Metadata
.... 8.79 Mapping of A.2 Order Information to FHIR profiles
.... 8.80 Mapping of A.3 Order Reason to FHIR profiles
.... 8.81 Mapping of A.4 Specimen
.... 8.82 Mapping of A.5.1 Imaging Procedure Description
.... 8.83 Mapping of A.5.2 Imaging Procedure Medication
.... 8.84 Mapping of A.5.3 Adverse reaction (Adverse reactions manifested during imaging investigation.
.... 8.85 Mapping of A.5.4 Results
.... 8.86 Mapping of A.5.5 Conclusion
.... 8.87 Mapping of A.5.6 Recommendation
.... 8.88 Mapping of A.6 Key images associated with this report
.... 8.89 Mapping of A.7 Comparison Study
.... 8.90 Mapping of A.8 Presented Form
.... 8.91 Mapping of B Imaging study manifest data set